AG regimen: Clinical Trials

2 trials of AG regimen, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 unknown. 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 32Completed 1, Unknown 1

Follow AG regimen: new trials by email Literature Review of AG regimen trials Research Report on AG regimen

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
AG vs mFOLFIRINOX as Neoadjuvant Therapy for Borderline Reseactable and Locally Advanced Pancreatic Cancer
Nab paclitaxel plus gemcitabine, mFOLFIRINOX - Borderline Resectable Pancreatic Cancer, Locally Advanced Pancreatic Adenocarcinoma
Phase 3UnknownFudan University3002021-09-012022-01-28
Sequential Use of AG and mFOLFIRINOX as Neoadjuvant Chemotherapy for Resectable Pancreatic Cancer
AG regimen, mFolfirinox - Pancreatic Adenocarcinoma Resectable, Neoadjuvant Chemotherapy
Phase 3CompletedSecond Affiliated Hospital, Zhejiang University, School of Medicine3242018-10-202025-05-13

Conditions studied

Pancreatic Neoplasms (1)

Sponsors

Fudan University (1)  ·  Second Affiliated Hospital, Zhejiang University, School of Medicine (1)

Countries

China (2)

Top investigators

Tingbo Liang, MD PhD (1)  ·  Xian-Jun Yu, MD, PhD (1)